Aelis Farma (France) Today
| AELIS Stock | 2.40 0.18 6.98% |
Performance0 of 100
| Odds Of DistressLess than 22
|
Aelis Farma is selling at 2.40 as of the 11th of December 2024; that is 6.98% down since the beginning of the trading day. The stock's last reported lowest price was 2.38. Aelis Farma has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 12th of September 2024 and ending today, the 11th of December 2024. Click here to learn more.
Moving together with Aelis Stock
| 0.67 | VLA | Valneva SE | PairCorr |
| 0.73 | ABVX | Abivax SA | PairCorr |
| 0.91 | IPH | Innate Pharma | PairCorr |
| 0.8 | TNG | Transgene SA | PairCorr |
Moving against Aelis Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aelis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aelis Farma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aelis Farma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Aelis Farma SA (AELIS) is traded on Euronext Paris in France and employs 22 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 177.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aelis Farma's market, we take the total number of its shares issued and multiply it by Aelis Farma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aelis Farma SA operates under Healthcare sector and is part of Biotechnology industry. The entity has 12.5 M outstanding shares.
Aelis Farma SA has accumulated about 24.71 M in cash with 18.97 M of positive cash flow from operations.
Check Aelis Farma Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Aelis Farma SA is USD177.77 Million. Almost 99.8 percent of Aelis Farma outstanding shares are held by general public with 0.2 % by other corporate entities. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Aelis Ownership Details
Aelis Farma SA Risk Profiles
Although Aelis Farma's alpha and beta are two of the key measurements used to evaluate Aelis Farma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.69 | |||
| Standard Deviation | 3.87 | |||
| Variance | 15.01 | |||
| Risk Adjusted Performance | (0.20) |
Aelis Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aelis Farma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Additional Tools for Aelis Stock Analysis
When running Aelis Farma's price analysis, check to measure Aelis Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aelis Farma is operating at the current time. Most of Aelis Farma's value examination focuses on studying past and present price action to predict the probability of Aelis Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aelis Farma's price. Additionally, you may evaluate how the addition of Aelis Farma to your portfolios can decrease your overall portfolio volatility.